Cargando…
Development of a panel of serum IgG and IgA autoantibodies for early diagnosis of colon cancer
Purpose: Our pilot study in a small cohort by ELISA showed that the levels and positive rates of serum IgG autoantibodies against p53, HRAS and NSG1, and IgA autoantibody against TIF1γ in early colon cancer (CC) group were significantly higher than that of colon benign lesion (CBL) group / healthy c...
Autores principales: | Chen, Meihong, Lin, Xiaoqing, Zhang, Liangming, Yu, Lili, Wu, Qingwei, Zhang, Songgao, Xue, Fangqin, Huang, Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7645342/ https://www.ncbi.nlm.nih.gov/pubmed/33162802 http://dx.doi.org/10.7150/ijms.50169 |
Ejemplares similares
-
The Combination of IgA and IgG autoantibodies against Transcriptional Intermediary Factor-1γ contributes to the early diagnosis of Lung Cancer
por: Yu, Lili, et al.
Publicado: (2020) -
Serum galactose-deficient-IgA1 and IgG autoantibodies correlate in patients with IgA nephropathy
por: Placzek, William J., et al.
Publicado: (2018) -
Galactose-deficient IgA1 and the corresponding IgG autoantibodies predict IgA nephropathy progression
por: Maixnerova, Dita, et al.
Publicado: (2019) -
Correction: Galactose-deficient IgA1 and the corresponding IgG autoantibodies predict IgA nephropathy progression
por: Maixnerova, Dita, et al.
Publicado: (2019) -
Serum IgA, IgM, and IgG responses in COVID-19
por: Ma, Huan, et al.
Publicado: (2020)